Aclaris Therapeutics, Inc. financial data

Symbol
ACRS on Nasdaq
Location
Wayne, PA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 399% % -33%
Debt-to-equity 45% % 43%
Return On Equity -52% % 45%
Return On Assets -36% % 50%
Operating Margin -976% % -29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 120,595,189 shares 12%
Common Stock, Shares, Outstanding 120,499,433 shares 12%
Entity Public Float $149,200,000 USD 96%
Common Stock, Value, Issued $1,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 122,564,741 shares 59%
Weighted Average Number of Shares Outstanding, Diluted 122,564,741 shares 59%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $7,826,000 USD -58%
Cost of Revenue $2,091,000 USD -25%
Research and Development Expense $52,645,000 USD 57%
General and Administrative Expense $21,972,000 USD -1%
Costs and Expenses $84,201,000 USD -48%
Operating Income (Loss) $76,375,000 USD 46%
Nonoperating Income (Expense) $11,452,000 USD 16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $64,923,000 USD 51%
Net Income (Loss) Attributable to Parent $64,923,000 USD 51%
Earnings Per Share, Basic -0.53 USD/shares 69%
Earnings Per Share, Diluted -0.53 USD/shares 69%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $19,960,000 USD -19%
Cash, Cash Equivalents, and Short-term Investments $151,400,000 USD -26%
Accounts Receivable, after Allowance for Credit Loss, Current $194,000 USD -40%
Assets, Current $96,316,000 USD -24%
Property, Plant and Equipment, Net $761,000 USD -25%
Other Assets, Noncurrent $2,771,000 USD -9.6%
Assets $160,460,000 USD -27%
Accounts Payable, Current $13,158,000 USD 181%
Employee-related Liabilities, Current $5,298,000 USD 6.4%
Accrued Liabilities, Current $8,791,000 USD -57%
Contract with Customer, Liability, Current $3,943,000 USD 1.4%
Liabilities, Current $28,645,000 USD -9.3%
Contract with Customer, Liability, Noncurrent $16,168,000 USD -19%
Operating Lease, Liability, Noncurrent $1,565,000 USD -26%
Other Liabilities, Noncurrent $1,565,000 USD -65%
Liabilities $57,378,000 USD -11%
Accumulated Other Comprehensive Income (Loss), Net of Tax $610,000 USD 529%
Retained Earnings (Accumulated Deficit) $967,784,000 USD -7.2%
Stockholders' Equity Attributable to Parent $103,082,000 USD -34%
Liabilities and Equity $160,460,000 USD -27%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $13,057,000 USD 37%
Net Cash Provided by (Used in) Financing Activities $275,000 USD -400%
Net Cash Provided by (Used in) Investing Activities $19,119,000 USD 14%
Common Stock, Shares Authorized 400,000,000 shares 100%
Common Stock, Shares, Issued 120,499,433 shares 12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $5,787,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19,960,000 USD -19%
Deferred Tax Assets, Valuation Allowance $197,111,000 USD -12%
Deferred Tax Assets, Gross $198,211,000 USD -12%
Operating Lease, Liability $2,116,000 USD -19%
Depreciation $400,000 USD -50%
Payments to Acquire Property, Plant, and Equipment $43,000 USD -68%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $64,410,000 USD 51%
Lessee, Operating Lease, Liability, to be Paid $2,511,000 USD -22%
Property, Plant and Equipment, Gross $5,795,000 USD -0.31%
Operating Lease, Liability, Current $551,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year Two $760,000 USD 2.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $711,000 USD 2.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.101 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $395,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid, Year Three $779,000 USD 2.5%
Deferred Tax Assets, Operating Loss Carryforwards $123,685,000 USD 2.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $260,000 USD -67%
Additional Paid in Capital $1,070,255,000 USD 1.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $128,000 USD -47%
Share-based Payment Arrangement, Expense $12,384,000 USD 14%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%